BCL2L2 and glioblastoma: To examine the effects of Bcl2l2‐Pabpn1 on glioblastoma development, we designed two shRNAs (Figure 4B) targeting the fusion junction of Bcl2l2‐Pabpn1 read‐through fusion transcript (NM_001199864.3).